Autotransfusion Devices Market Size

  • Report ID: 4459
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Autotransfusion Devices Market Outlook:

Autotransfusion Devices Market size was valued at USD 439.23 million in 2025 and is set to exceed USD 779.2 million by 2035, registering over 5.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of autotransfusion devices is estimated at USD 462.55 million.

The growth of the market can primarily be ascribed to the number of patients in need of surgical care. As per the WHO, over 2 million surgical procedures were performed in 2018 across the globe. Moreover, instances of surgical burden are to expected rise by approximately 30% in the next few years.

The rising need for blood donation and increased volumes of donated blood, combined with the rising need for blood transfusion, is expected to boost the growth of the global autotransfusion devices market. As per the reported data, globally, every year about 118.5 million units of donated blood are collected. Additionally, in India, nearly 25-30 thousand people require liver transplants and about 50,000 person gets a heart attack. Furthermore, around 6,721 people are waiting for organ transplantation in the United Kingdom.

Autotransfusion is the procedure of transferring a patient's own blood into their body during cardiac or orthopedic surgery after component separation, and filtration. On the other hand, allogeneic blood transfusions can result in tumor progression, post-operative infections, severe lung injury, post-operative cardiovascular failures, and early death. For instance, multiple patient-based analysts predict that the pervasiveness of transfusion-associated circulatory overload (TACO) and transfusion-related acute lung injury (TRALI) in the United States is about 1.0% and 0.1%, respectively. As a result, shifting the priority forward into cell salvage can greatly decrease the need for allogeneic blood transfusion, decreasing the likelihood of detrimental ailments. As a result, the switch toward autologous blood transfusion is an eminent trend that is predicted to drive the market’s growth.


Autotransfusion Devices Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of autotransfusion devices is estimated at USD 462.55 million.

The global autotransfusion devices market size crossed USD 439.23 million in 2025 and is likely to register a CAGR of over 5.9%, exceeding USD 779.2 million revenue by 2035.

The Asia Pacific autotransfusion devices market commands the largest share by 2035, driven by entry of new players, expanding surgeries, and acceptance of cell salvage technologies.

Key players in the market include ProCell Surgical Inc,BD (Becton, Dickinson and Company), Fresenius SE & Co. KGaA, Medtronic, Beijing Jingjing Medical Equipment Co., Ltd., Haematonics Corporation, LivaNova PLC, Zimmer Biomet, SARSTEDT AG & Co. KG, Gen World Medical Devices.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos